A Phase II Study of FOLFOXIRI Plus Panitumumab Followed by...

The Oncologist 2016 / 03 Vol. 21; Iss. 3

A Phase II Study of FOLFOXIRI Plus Panitumumab Followed by Evaluation for Resection in Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only

Bendell, J. C., Zakari, A., Peyton, J. D., Boccia, R., Moskowitz, M., Gian, V., Lipman, A., Waterhouse, D., LoCicero, R., Earwood, C., Lane, C. M., Meluch, A.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
21
Language:
english
Journal:
The Oncologist
DOI:
10.1634/theoncologist.2015-0439
Date:
March, 2016
File:
PDF, 541 KB
english, 2016
Conversion to is in progress
Conversion to is failed